It’s Sunday at 7 pm. You walk into your ED and there are three patients sitting there looking at you anxiously, with that sick but not quite crashing look on their faces.

The first patient is a 15-year-old female. Her vitals are borderline abnormal and she’s staring at you with drool slowly dripping down her chin. 

The second patient is a decade older, male, normotensive, tachycardic to 128/min, tachypneic to 25/min, but “satting” just fine. He’s not working harder to breathe than you are, but he keeps saying the same thing over and over, like an echo, “I just can’t catch my breath doc”. 

The last patient is 45, “county normotensive” at 161/94, with otherwise normal vitals. He is staring at you through one eye. The other eye is closed tightly shut, so you ask him why, to which he curtly responds, “I’d rather speak to one of you than two of you”.

While quickly reviewing the chart of these three patients you realize they all have one thing in common: they take pyridostigimine a couple times a day. Naturally, you inquire about the only disease process you can remember that requires this medication, to which they all, like clockwork, respond, “Yes, I have Myasthenia Gravis.”

Myasthenia Gravis, Myasthenia Gravis… you haven’t seen someone with this since med school, and haven’t thought about it much since then either. You feel like you know nothing about it, but thankfully you have me, the little subconscious voice in your head that was actually semi-listening to that lecture on Myasthenia Gravis (MG) two weeks ago in conference: it’s the most common neuromuscular disorder we know of, it usually affects women earlier than it affects men, like 3rd versus 6th decade, and it is autoimmune.

What does MG actually do to people?

It’s a simple mechanism. People form antibodies to their own acetylcholine receptors which does two things:

First, it blocks endogenous acetylcholine from binding to their receptors, and if acetylcholine can’t bind, the patient’s muscles can’t contract. 

Second, like what happens when antibodies bind to most things, it causes complement-mediated destruction of acetylcholine receptors throughout the day, essentially depleting the number of receptors available as the day goes on. 

In sum, these people wake up in the morning as strong as they are going to be for the day, then become weaker as the day goes on. Their muscular weakness generally improves with rest and worsens with repetitive muscular activity.

You look back at those patients who are still looking at you, drooling, eyes anxiously wide, or one eye anxiously wide, and you start putting it together – they’re all having a myasthenic crisis. 

Wait, are they?

 

A crisis is any worsening of baseline MG causing or threatening to cause respiratory failure (1). 

A myasthenic crisis usually presents with a shockingly varied array of complaints. You still remember the image on that slide entitled “Presentation”:

Diplopia, Drooling, Dyspnea, Dysphagia, Dysarthria, Opthomoplegia

A crisis usually starts out as bulbar muscular weakness, which can then spread to proximal muscles – deltoids, biceps, quadriceps. The weakness than can become general, even affecting the diaphragm and requiring intubation.

You’re starting to panic now, but silently. No one sees this or knows this but you and me. You are concerned about these patients, and you should be. I mean, they’re diving into the depths of a myasthenic crisis right now, and you’re just standing there watching them. You should probably do something, right? That’s what EM docs do. We do things. We don’t stand around and think – but maybe you should, for just a little longer, think. 

Then it hits you. You remember a picture from the presentation. How could you not? It’s from the best movie of all time. 

You remember exactly what you need to do when faced with a patient, or three, with MG.

You need to choose one of two options

The first option, the blue pill if you will, is to use the patient’s history of MG to explain whatever the patient’s chief complaint is. This is easy and tempting because MG is notoriously good at mimicking a wide variety of other diseases. 

The second option, the red pill, is to think outside the box. What else can explain these patient’s chief complaints? Form a differential.

Why waste time though? Its most likely Myasthenic Crisis.

Maybe it is, but here’s the issue with relying on this: 

Not only does Myasthenic Crisis mimic multiple other diseases, but multiple other diseases can also trigger a Myasthenic Crisis (1-6). 

So you gain two things by going through a differential: first, peace of mind from crossing possibilities off your list; second, maybe you actually find whatever it is that was triggering this crisis to begin with, allowing you to treat it.

Common MG triggers are infectious, cardio-pulmonary and endocrine pathologies, physical pain, electrolyte abnormalities, hyperthermia, anemia, medications, and even emotional stress. 

So consider a broader work up: CMP, CBC, EKG, TFTs, Troponin, UA and chest X-ray. Ask about recent physical trauma or emotional stress, and importantly, get a current medication list.

You look back at your drooling patient and realize your own throat feels like it’s closing up. You look at your dyspneic patient and realize your own breathing is becoming short. You look at your diplopic patient and realize these three patients are starting to feel like they’re multiplying.

Who is going to crash first?

There is one primary thing and two additional things you can do to assess impending respiratory failure. 

Primarily, of course, is ABCs. You may not have much experience with MG patients, but with your emergency medicine training, you should have plenty of experience with patients who look like they can’t breathe. Any sign that would concern you in any other patient, should concern you in an MG patient. 

The first additional evaluation is the Single Breath Count Test. It’s easy, just ask the patient to take a breath and count as high as they can without taking another breath. The lower the number they have to stop at, the higher your concern should be. Normal is over 30, under 20 is concerning (1,2).

The second additional evaluation is Pulmonary Function Testing (PFTs). It includes Vital Capacity (VC) and Negative Inspiratory Force (NIF), and they usually require a respiratory therapist to bring down equipment.  

To assess VC: the respiratory therapist is going to have the patient take a full inhalation followed by a full exhalation, and the volume of air moved is measured. Normal is greater than 60 ml/kg, or around 3 to 5 Liters. Any value under 20 ml/kg should make you more concerned, so set up airway stuff faster and get consultants involved quicker (1,2). 

To assess NIF: the respiratory therapist is going to have the patient inhale as hard as he or she can, and the amount of negative pressure generated is measured. Normal values are around 60 cmH2O. Any value under 30 cmH20 should also make you move faster (1,2).

Wait.

You start thinking more about PFTs, you start questioning, like the inquisitive ER doc you were trained to be. If MG worsens with repetitive muscular activity, should I really be asking these potential Myasthenic Crisis patients to be breathing as hard as they can repeatedly?

PFTs are incredibly effort and position-dependent, often generating values that vary widely (2). The more effort these patients put into it, the better the values will likely be, but also the more tired their muscles will likely get. If you’re concerned about impending respiratory failure, it’s probably prudent to not overdo these. 

The studies evaluating these tests are generally low quality, retrospective, and have no sensitivities or specificities reported. , In these studies, NIF was uniformly found to be less consistent and less informative than VC. It may be worth remembering that the studies were actually done on Guillain-Barre patients, not MG patients (7-13). 

Food for thought.

When I figure out which patient I think is likely to crash, what do I do down here in the ED?

While there are medications for MG with cool, cutting edge mechanisms like acetylcholinesterases, pulse dose steroids, plasmapheresis, and IVIG; in the acute ED setting you have two simple principles of management:

First – Minimize Medications

You know that many medications, including corticosteroids, can trigger a crisis, so the fewer meds we add to the suspect list the better. Acetylcholinesterases seem intuitive but they are actually known to complicate the situation with increased airway secretions and cardiac dysrhythmias (1). Plasmapheresis and IVIG are typically the only useful medical therapy for a severe crisis, however, these medications should be given in conjunction with neurological consultation or within an ICU setting (1). 

Second – Reduce Work of Breathing

You know their respiratory muscles are getting weaker, so your goal is to make the act of breathing easier than it normally is so that these muscles are still effective. You can do this by not over-exerting these patients with things like frequently repeated PFTs, and by having a low threshold for starting NIPPV, like high flow nasal cannula or BIPAP (14-18).

What if I have to intubate?

Just make sure you’ve done everything you can prior because these patients are notoriously difficult to extubate which leads to longer ICU admissions and higher likelihood for in hospital complications. If you have to intubate, you have to intubate. Keep these two thoughts in mind:

First – Less Roc, More Sux

Non-depolarizing neuromuscular blockers just bind to acetylcholine receptors and prevent native acetylcholine from binding, causing paralysis. Since there are fewer acetylcholine receptors available, you can use less rocuronium– typically half the dose (1,2). 

Succinylcholine works by binding acetylcholine receptors and causing a massive muscular contraction with subsequent inability to repolarize, causing paralysis. Since there are fewer acetylcholine receptors available, you need to use more succinylcholine– typically 1.5x the dose (1,2).

Second – Sedate Appropriately

No matter which paralytic you use, you can count on the paralysis lasting 2-4 times longer in patients with MG. So don’t be cruel, sedate appropriately (1,2.

 

Summary

You took the blue pill.

You didn’t question the crisis.

You panicked.

You called Respiratory Therapy.

You consulted MICU.

You overhead paged Neurology.

You took the red pill.

You questioned the crisis.

You formed a differential. 

You found the 15 year old’s Peritonsillar Abscess.

You terminated the 25 year old’s Paroxysmal SVT. 

You still overhead paged neurology, but for a brainstem stroke.


 

 

 References

1. Roper J, Fleming ME, Long B, Koyfman A. Myasthenia Gravis and Crisis: Evaluation and Management in the Emergency Department. J Emerg Med. 2017 Dec;53(6):843-853

2. J. Farkas. Myasthenia gravis and Myasthenic Crisis. The Internet Book of Critical Care. March 6, 2019.

3. J. Morgenstern. Myasthenic Crisis. First10EM. March 8, 2019.

4. C. Nickson. Myasthenia Gravis. Life in the Fastlane. April 17, 2019.

5. Myasthenia Gravis. WikiEM. May 3, 2019.

6. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, 7e (2010), Chapter 167. Chronic Neurologic Disorders

7. Lawn N, Fletcher D, Henderson R, Wolter T, Wijdicks E. Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol. 2001;58(6):893-898.

8. Sunderrajan E, Davenport J. The Guillain-Barré syndrome: pulmonary-neurologic correlations. Medicine (Baltimore). 1985;64(5):333-341.

9. Chevrolet J, Deléamont P. Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barré syndrome. Am Rev Respir Dis. 1991;144(4):814-818.

10. Sharshar T, Chevret S, Bourdain F, Raphaël J, French C. Early predictors of mechanical ventilation in Guillain-Barré syndrome. Crit Care Med. 2003;31(1):278-283.

11. Durand M, Porcher R, Orlikowski D, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study. Lancet Neurol. 2006;5(12):1021-1028.

12. Kannan K, Durga P, Venigalla N, Kandadai R, Jabeen S, Borgohain R. Simple bedside predictors of mechanical ventilation in patients with Guillain-Barre syndrome. J Crit Care. 2014;29(2):219-223.

13. Rieder P, Louis M, Jolliet P, Chevrolet J. The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis. Intensive Care Med. 1995;21(8):663-668.

14. Rabinstein A, Wijdicks EF. BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation. Neurology. 2002 Nov 26;59(10):1647-9. doi: 10.1212/01.wnl.0000033797.79530.16. PubMed PMID: 12451217.

15. Wu JY, Kuo PH, Fan PC, Wu HD, Shih FY, Yang PC. The role of non-invasive ventilation and factors predicting extubation outcome in myasthenic crisis.Neurocrit Care. 2009;10(1):35-42. doi: 10.1007/s12028-008-9139-y. Epub 2008 Sep 20. PubMed PMID: 18810663.

16. Seneviratne J, Mandrekar J, Wijdicks EF, Rabinstein AA. Noninvasive ventilation in myasthenic crisis. Arch Neurol. 2008 Jan;65(1):54-8. doi: 10.1001/archneurol.2007.1. PubMed PMID: 18195139.

17. Prigent H, Orlikowski D, Letilly N, Falaize L, Annane D, Sharshar T, Lofaso F. Vital capacity versus maximal inspiratory pressure in patients with Guillain-Barré syndrome and myasthenia gravis. Neurocrit Care. 2012 Oct;17(2):236-9. doi: 10.1007/s12028-011-9575-y. PubMed PMID: 21748507.

18. J. Farkas. Five Pearls for the dyspneic patient with Guillan-Barre Syndrome or Myasthenia Gravis. PulmCrit. Feb 22, 2015

The following two tabs change content below.

Julian

Latest posts by Julian (see all)


0 Comments

Leave a Reply

Avatar placeholder

Your email address will not be published. Required fields are marked *

%d bloggers like this: